OM - Outset Medical, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
San Jose,
United States
Type: Equity
OM price evolution
OM
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $41.19 | $35.51 | $71.84 | |
| Short term investments | $156.99 | $194.74 | $134.81 | |
| Net receivables | $34.26 | $34.12 | $36.48 | $32.98 |
| Inventory | $61.44 | $61.6 | $55.84 | $49.22 |
| Total current assets | $275.27 | $295.14 | $325.39 | $291.22 |
| Long term investments | ||||
| Property, plant & equipment | $13.8 | $15.55 | $16.98 | $18.65 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $19.4 | $20.85 | $22.58 | |
| Total investments | $156.99 | $194.74 | $134.81 | |
| Total assets | $292.89 | $314.53 | $346.24 | $313.8 |
| Current liabilities | ||||
| Accounts payable | $4.29 | $5.25 | $6.77 | $5.83 |
| Deferred revenue | $13.24 | $13.03 | $11.83 | |
| Short long term debt | $1.69 | $1.64 | $1.59 | |
| Total current liabilities | $42.43 | $43.43 | $50.67 | $55.32 |
| Long term debt | $197.18 | $200.61 | $200.87 | $134.59 |
| Total noncurrent liabilities | $202.5 | $202.37 | $135.59 | |
| Total debt | $202.3 | $202.51 | $136.19 | |
| Total liabilities | $245.07 | $245.94 | $253.04 | $190.91 |
| Shareholders' equity | ||||
| Retained earnings | -$1064.09 | -$1036.14 | -$1001.69 | -$961.75 |
| Other shareholder equity | -$0.3 | -$0.26 | $0.07 | |
| Total shareholder equity | $68.6 | $93.2 | $122.89 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $71.84 | $76.53 | $215.66 | $328.28 |
| Short term investments | $134.81 | $214.28 | $157.14 | $19.9 |
| Net receivables | $32.98 | $28.07 | $25.6 | $6.47 |
| Inventory | $49.22 | $51.48 | $39.19 | $18.38 |
| Total current assets | $291.22 | $373.64 | $409.8 | $345.91 |
| Long term investments | ||||
| Property, plant & equipment | $18.65 | $21.99 | $20.2 | $23.25 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $22.58 | $26.47 | $53.66 | $57.92 |
| Total investments | $134.81 | $214.28 | $157.14 | $19.9 |
| Total assets | $313.8 | $400.12 | $463.46 | $403.83 |
| Current liabilities | ||||
| Accounts payable | $5.83 | $0.6 | $1.76 | $4.95 |
| Deferred revenue | $11.83 | $8.81 | $6.65 | $3.77 |
| Short long term debt | $1.59 | $1.32 | $1.15 | $0.88 |
| Total current liabilities | $55.32 | $51.95 | $51.7 | $36.69 |
| Long term debt | $134.59 | $96.34 | $36.66 | $37.72 |
| Total noncurrent liabilities | $135.59 | $102.18 | $37.69 | $38.53 |
| Total debt | $136.19 | $103.23 | $37.81 | $38.6 |
| Total liabilities | $190.91 | $154.13 | $89.38 | $75.22 |
| Shareholders' equity | ||||
| Retained earnings | -$961.75 | -$788.95 | -$625.99 | -$494.06 |
| Other shareholder equity | $0.07 | -$0.56 | -$0.18 | $0 |
| Total shareholder equity | $122.89 | $245.99 | $374.08 | $328.61 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $28.67 | $27.39 | $28.17 | $30.51 |
| Cost of revenue | $17.61 | $19.95 | $22.8 | |
| Gross Profit | $9.82 | $9.78 | $8.21 | $7.71 |
| Operating activities | ||||
| Research & development | $9.73 | $12.63 | $12.53 | |
| Selling, general & administrative | $30.81 | $32.49 | $32.53 | |
| Total operating expenses | $33.66 | $40.55 | $45.13 | $45.06 |
| Operating income | -$30.76 | -$36.91 | -$37.35 | |
| Income from continuing operations | ||||
| EBIT | -$28.29 | -$33.81 | -$35.07 | |
| Income tax expense | $0.18 | $0.15 | $0.16 | $0.11 |
| Interest expense | -$3.92 | $6.01 | $5.97 | $3.42 |
| Net income | ||||
| Net income | -$27.94 | -$34.45 | -$39.94 | -$38.6 |
| Income (for common shares) | -$34.45 | -$39.94 | -$38.6 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $130.38 | $115.38 | $102.6 | $49.94 |
| Cost of revenue | $101.38 | $97.54 | $94.99 | $62.97 |
| Gross Profit | $29 | $17.83 | $7.61 | -$13.04 |
| Operating activities | ||||
| Research & development | $57.31 | $48.85 | $36.74 | $28.85 |
| Selling, general & administrative | $141.46 | $130 | $101.39 | $75.58 |
| Total operating expenses | $198.77 | $178.85 | $138.13 | $104.43 |
| Operating income | -$169.77 | -$161.02 | -$130.52 | -$117.47 |
| Income from continuing operations | ||||
| EBIT | -$159.6 | -$159.09 | -$130.02 | -$118.6 |
| Income tax expense | $0.52 | $0.29 | $0.2 | |
| Interest expense | $12.68 | $3.57 | $1.72 | $2.89 |
| Net income | ||||
| Net income | -$172.8 | -$162.96 | -$131.94 | -$121.49 |
| Income (for common shares) | -$172.8 | -$162.96 | -$131.94 | -$79.32 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$34.45 | -$39.94 | -$38.6 | |
| Operating activities | ||||
| Depreciation | $1.82 | $1.81 | $1.8 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $9.82 | $8.2 | $9.1 | |
| Total cash flows from operations | -$33.34 | -$45.91 | -$24.44 | |
| Investing activities | ||||
| Capital expenditures | -$0.12 | -$0.35 | -$1.05 | |
| Investments | $39.06 | -$58.68 | $24.48 | |
| Total cash flows from investing | -$4.21 | $38.94 | -$59.03 | $23.43 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.08 | $2.09 | $0 | |
| Net borrowings | $66.52 | $33.23 | ||
| Total cash flows from financing | $68.81 | $0.08 | $68.61 | $33.23 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$35.22 | $5.68 | -$36.33 | $32.21 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$172.8 | -$162.96 | -$131.94 | -$121.49 |
| Operating activities | ||||
| Depreciation | $7.08 | $6.28 | $6.18 | $3.75 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $38.63 | $27.2 | $17.45 | $21.44 |
| Total cash flows from operations | -$131.37 | -$145.73 | -$130.26 | -$99.02 |
| Investing activities | ||||
| Capital expenditures | -$3.44 | -$8.32 | -$3.11 | -$9.08 |
| Investments | $86.47 | -$57.97 | -$139.4 | $13.02 |
| Total cash flows from investing | $83.03 | -$66.3 | -$142.51 | $3.95 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.43 | $8.04 | $160.15 | $256 |
| Net borrowings | $33.23 | $64.86 | -$1.36 | |
| Total cash flows from financing | $43.65 | $72.9 | $160.15 | $385.68 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$4.7 | -$139.13 | -$112.62 | $290.61 |
News
Fundamentals
| Market cap | $47.23M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 52.54M |
| Revenue | $114.73M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$140.94M |
| Revenue Q/Q | -5.59% |
| Revenue Y/Y | -13.00% |
| P/E ratio | -0.34 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.41 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$2.68 |
|---|---|
| ROA | -44.48% |
| ROE | N/A |
| Debt/Equity | 1.55 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 6.49 |
| Quick ratio | 5.04 |